Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Tissue-based molecular markers for bladder cancer.

C E Barbieri¹, Y Lotan, R K Lee

¹Department of Urology, Weill Cornell Medical Center, New York, NY, USA. sfshariat@gmail.com

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology

|October 14, 2010

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nivolumab plus gemcitabine-cisplatin for unresectable or metastatic urothelial carcinoma: health-related quality-of-life analyses from the phase III CheckMate 901 trial.

ESMO open·2026

Same author

Analysis of active surveillance uptake for localized prostate cancer in Quebec in 2016: A Canadian bicentric study and comparison with 2010 data.

The French journal of urology·2023

Same author

Work-related injuries and attendance at a Canadian regional emergency department.

Occupational medicine (Oxford, England)·2023

Same author

Pediatric Cardiology Fellowship Standards for Training in Exercise Medicine and Curriculum Outline.

Pediatric cardiology·2022

Same author

The current role of precision surgery in oligometastatic prostate cancer.

ESMO open·2022

Same author

Trial Participation is Not Associated with Better Biochemical Recurrence-free Survival in a Large Cohort of External Beam Radiotherapy-Treated Intermediate- and High-Risk Prostate Cancer Patients.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022

Same journal

Trimodal therapy in muscle invasive bladder cancer management.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020

Same journal

Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020

Same journal

Bowel suture technique for bladder neck reconstruction during RALP and its impact on early continence recovery.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020

Same journal

Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand?

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020

Same journal

Functional and oncological outcomes of 3D clampless sutureless laparoscopic partial nephrectomy for renal tumors with low nephrometry score.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020

Same journal

Robot-assisted laparoscopic pyeloplasty in children: a systematic review.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020

See all related articles

Molecular bladder cancer markers show promise for improving prognostics and treatment selection. Combining these tissue-based markers may enhance clinical decision-making for urothelial carcinoma.

Area of Science:

Oncology
Urology
Molecular Pathology

Background:

Bladder cancer, a prevalent genitourinary malignancy, presents poor survival rates for muscle-invasive urothelial carcinoma despite aggressive treatments.
Current prognostic tools based on stage and grade offer limited predictive accuracy, leading to significant patient outcome heterogeneity.
Molecular profiling of bladder cancer is revealing key pathogenic mechanisms and potential tissue-based biomarkers.

Purpose of the Study:

To review recent advancements in tissue-based molecular markers for bladder cancer.
To discuss the potential utility of these markers in improving prognostic information and guiding therapeutic strategies.
To address considerations for the development and validation of molecular markers.

Main Methods:

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Experiment Videos

Last Updated: Jun 8, 2026

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Literature review of recent research on molecular markers in bladder cancer.
Analysis of potential prognostic and predictive utility of identified markers.
Discussion of statistical and design considerations for marker development.

Main Results:

Emerging molecular markers offer potential for more accurate bladder cancer prognostication.
These markers may aid in selecting appropriate therapeutic strategies for individual patients.
A combination of molecular markers is likely to provide a more comprehensive assessment of tumor biology.

Conclusions:

Tissue-based molecular markers represent a significant advancement in understanding and managing bladder cancer.
Improved risk stratification through molecular markers can lead to more personalized treatment approaches.
Further research and validation are crucial for integrating molecular markers into clinical practice for bladder cancer.